The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism
Abstract
The recent cloning of the gene encoding the sodium/iodide symporter (NIS) has enabled better characterization of the molecular mechanisms underlying iodide transport, thus opening the way to clarifying its role in thyroid diseases. Several studies, at both the mRNA and the protein expression levels, have demonstrated that TSH, the primary regulator of iodide uptake, upregulates NIS gene expression and NIS protein abundance, both in vitro and in vivo. However, other factors, including iodide, retinoic acid, transforming growth factor-beta, interleukin-1alpha and tumour necrosis factor alpha, may participate in the regulation of NIS expression. Investigation of NIS mRNA expression in different thyroid tissues has revealed increased levels of expression in Graves' disease and toxic adenomas, whereas a reduction or loss of NIS transcript was detected in differentiated thyroid carcinomas, despite the expression of other specific thyroid markers. NIS mRNA was also detected in non-thyroid tissues able to concentrate radioiodine, including salivary glands, stomach, thymus and breast. The production of specific antibodies against the NIS has facilitated study of the expression of the symporter protein. Despite of the presence of high levels of human (h)NIS mRNA, normal thyroid glands exhibit a heterogeneous expression of NIS protein, limited to the basolateral membrane of the thyrocytes. By immunohistochemistry, staining of hNIS protein was stronger in Graves' and toxic adenomas and reduced in thyroid carcinomas. Measurement of iodide uptake by thyroid cancer cells is the cornerstone of the follow-up and treatment of patients with thyroid cancer. However, radioiodide uptake is found only in about 67% of patients with persistent or recurrent disease. Several studies have demonstrated a decrease in or a loss of NIS expression in primary human thyroid carcinomas, and immunohistochemical studies have confirmed this considerably decreased expression of the NIS protein in thyroid cancer tissues, suggesting that the low expression of NIS may represent an early abnormality in the pathway of thyroid cell transformation, rather than being a consequence of cancer progression. The relationship between radioiodine uptake and NIS expression by thyroid cancer cells require further study. New strategies, based on manipulation of NIS expression, to obtain NIS gene reactivation or for use as NIS gene therapy in the treatment of radiosensitive cancer, are also being investigated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
One- and two-step transformations of rat thyroid epithelial cells by retroviral oncogenes.
Fusco, A., Berlingieri, M. T., Di Fiore, P. P., Portella, G., Grieco, M., & Vecchio, G. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.9.3365 · Cited by 270
RetractedPapillary and Follicular Thyroid Carcinoma
Schlumberger, M. J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380506 · Cited by 1,623
Self-citationCloning and characterization of the thyroid iodide transporter
Dai, G., Levy, O., & Carrasco, N. (1996) · Nature · doi:10.1038/379458a0 · Cited by 1,109
The Pendred syndrome gene encodes a chloride-iodide transport protein
Scott, D. A., Wang, R., Kreman, T. M., Sheffield, V. C., & Karniski, L. P. (1999) · Nature Genetics · doi:10.1038/7783 · Cited by 567
Cloning of the Human Sodium Iodide Symporter
Smanik, P. A., Liu, Q., Furminger, T. L., Ryu, K., Xing, S., Mazzaferri, E. L., & Jhiang, S. M. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1358 · Cited by 518
Schlumberger, M. J., Vathaire, C. C.-D., de Vathaire, F., Travagli, J. P., Gardet, P., Lumbroso, J., Francese, C., Fontaine, F., Ricard, M., & Parmentier, C. (1996) · PubMed · Cited by 498
Self-citationLadenson, P. W., Braverman, L. E., Mazzaferri, E. L., Brucker-Davis, F., Cooper, D. S., Garber, J. R., Wondisford, F. E., Davies, T. F., DeGroot, L. J., Daniels, G. H., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709253371304 · Cited by 466
Radioiodsne-131 In the Diagnosis and Treatment of Metastatic Weil Differentiated Thyroid Cancer
Maxon, H. R., & Smith, H. S. (1990) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30317-7 · Cited by 409
Spitzweg, C. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.5.1746 · Cited by 376
Iodide transport in the thyroid gland
Carrasco, N. (1993) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(93)90017-i · Cited by 365
Cited by
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
Chornokur, G., Lin, H.-Y., Tyrer, J. P., Lawrenson, K., Dennis, J., Amankwah, E. K., Qu, X., Tsai, Y.-Y., Jim, H. S. L., Chen, Z., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0128106 · Cited by 902
The Sodium/Iodide Symporter (NIS): Characterization, Regulation, and Medical Significance
Dohán, O., De la Vieja, A., Paroder, V., Riedel, C., Artani, M., Reed, M., Ginter, C. S., & Carrasco, N. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0029 · Cited by 861
BRAF Mutations in Papillary Thyroid Carcinomas Inhibit Genes Involved in Iodine Metabolism
Durante, C., Puxeddu, E., Ferretti, E., Morisi, R., Moretti, S., Bruno, R., Barbi, F., Avenia, N., Scipioni, A., Verrienti, A., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2707 · Cited by 397
Self-citationBonnema, S. J., & Hegedüs, L. (2012) · Endocrine Reviews · doi:10.1210/er.2012-1030 · Cited by 339
New therapeutic approaches for metastatic thyroid carcinoma
Baudin, E., & Schlumberger, M. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70034-7 · Cited by 143
Self-citation
Metadata
- Authors
- Filetti, S., Bidart, J., Arturi, F., Caillou, B., Russo, D., & Schlumberger, M.
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-11-01
- Volume
- 141
- Issue
- 5
- Pages
- 443-457
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2101651692
- Cited by
- 269
- References
- 39
- FWCI
- 8.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism. https://app.cochat.ai/papers/10.1530/eje.0.1410443
- The paper
- Filetti, S., Bidart, J., Arturi, F., Caillou, B., Russo, D., & Schlumberger, M. (1999). Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism. European Journal of Endocrinology. https://doi.org/10.1530/eje.0.1410443
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.